|
CNTLN expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
<1E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
3.303600E-01 |
| Stage1-vs-Stage3 |
6.516800E-01 |
| Stage1-vs-Stage4 |
3.019400E-01 |
| Stage2-vs-Stage3 |
5.919600E-01 |
| Stage2-vs-Stage4 |
9.736000E-01 |
| Stage3-vs-Stage4 |
5.643400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
3.71620000327866E-08 |
| Normal-vs-Asian |
1.65945035490722E-12 |
| Caucasian-vs-AfricanAmerican |
1.324830E-01 |
| Caucasian-vs-Asian |
2.217200E-01 |
| AfricanAmerican-vs-Asian |
6.058000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
2.482000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
4.15959999999771E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.010400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.356600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.718000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.134200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.455000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.432400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.845830E-01 |
| Classical-VS-Follicular |
4.963800E-01 |
| Classical-VS-Other |
7.893800E-02 |
| Classical-VS-Normal |
1.62625468647093E-12 |
| Tall-VS-Follicular |
5.025800E-01 |
| Tall-VS-Other |
3.051400E-01 |
| Tall-VS-Normal |
9.2148511043888E-15 |
| Follicular-VS-Other |
2.082000E-01 |
| Follicular-VS-Normal |
1.62436730732907E-12 |
| Other-VS-Normal |
1.24589999994651E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62458935193399E-12 |
| Normal-vs-N1 |
1.11022302462516E-16 |
| N0-vs-N1 |
7.530800E-01 |
|
|
